CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.
about
The innate immune system in demyelinating diseaseNeuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1Involvement of beta-chemokines in the development of inflammatory demyelinationCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisDouble Roles of Macrophages in Human Neuroimmune Diseases and Their Animal ModelsMultiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and MacrophagesMicroglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In VivoChemokines and chemokine receptors: update on utility and challenges for the clinician.It's a cell-eat-cell world: autophagy and phagocytosis.The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targetingMonocyte recruitment during infection and inflammationDifferential roles of microglia and monocytes in the inflamed central nervous systemIntracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathwayHaplotypes within genes of beta-chemokines in 17q11 are associated with multiple sclerosis: a second phase study.Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro.Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta.A novel highly potent therapeutic antibody neutralizes multiple human chemokines and mimics viral immune modulation.Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patientsNew therapeutics that modulate chemokine networks.Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis.Emerging disease modifying therapies for multiple sclerosis.SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS.CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaquesCC chemokine receptor 8 in the central nervous system is associated with phagocytic macrophages.Remyelinating and neuroprotective treatments in multiple sclerosis.Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.Immunologic correlates of MS pathologic subtypes.Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesionsCCR1 antagonists in clinical development.Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2.The formation of inflammatory demyelinated lesions in cerebral white matter.CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro.Brain endothelial dysfunction in cerebral adrenoleukodystrophy.Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions.
P2860
Q24597958-25A1D953-8277-4DA7-BCB1-E0AA2FF57890Q24645165-FCA8B31C-4AB5-4FA6-8C29-C09EFF02BBE1Q24801279-D6B3A752-7C9B-42B4-AD7C-8EE473B8AE63Q26740330-2C4CBD0B-AA0B-421D-9358-80F323A829F3Q26749131-15E16BC0-972A-495A-8502-EA76402D220FQ26770661-DA2B4E27-BB56-4091-8075-3DB283C19683Q26798185-31B20953-03B7-4D78-A33F-1A8F8C492D3DQ27687402-28D8C184-4793-402A-917D-A416F96077EFQ27691411-F3C34E97-9D85-4824-8704-BECF826DE329Q28299076-8E9D7099-0190-426D-8BED-D384D505422EQ29620067-52B85273-80A3-40F1-A675-051A8D737EBEQ30585165-FCF69924-DA38-4DF9-B61F-21F1FF13D4FDQ30724821-1CC84572-FC3E-4443-B38A-0334FE652AE4Q33221007-24C69A10-0A42-4C18-8149-F02E043572EDQ33775611-698458EA-EA8C-4677-8E68-58CFC8A2E28BQ33841113-29B53F42-49B5-430F-A475-731ACD4E7795Q33905233-58B2E13E-B0C6-4430-BA58-4FC502398912Q34076041-8AC3951E-6B5A-4276-B5DB-4073CD1855B0Q34089994-02782223-52CC-4005-A153-2F6CB45682E8Q34117705-A5A284E2-4F41-4F33-8426-4E456B79CE2EQ34389532-6DCC79D8-79D6-4557-B743-286732CC7C26Q34462248-C4F4F1B4-4874-4C97-A106-CA086776AD3EQ34532418-83B473F4-9876-4841-AA55-7753B00853CEQ34743328-E29A56F5-7BFA-4A60-91AE-838ABD9C1D3AQ35167056-17147616-00C0-47A5-8140-E71AD4FCBD3FQ35581158-36B2649E-F62E-4BA2-95E7-8A28C6E0889EQ35669020-59D6F6C7-C14F-4FD8-B3C1-5CE21EE8619DQ35693333-C2E14CAF-E15A-4D5A-8CEE-07625C68A5D4Q35748920-B6303D4C-19E2-405E-BE01-21714F43D7A9Q35753458-A10C890C-BFA3-401C-B78E-1BE0129F9FA6Q35825040-4D3DB600-95BF-4414-876F-C298F972D55AQ36054797-24914B33-A6A0-4AE8-9F52-4FBC7327AA05Q36072420-8EC9CDA7-9D5A-470D-A02E-A31C41FA980EQ36196440-CD8E8A1A-4C9D-4181-AF6D-2DBF8B70D9C3Q36410286-E96C10B4-59CC-4445-934B-A2B51400EF85Q36430868-66B82878-9381-4654-BFBB-40A9353468E9Q36490829-F3AC1F2C-9893-44A8-BE87-CFAE16F2A6A4Q36497113-AC97D962-7A73-40C4-ADE7-31DD0C2B56C9Q36515946-C2A23A0C-9CFB-4BA2-8AA3-CDF6E8ECDA75Q36586942-6B4678C2-A9C1-4615-AD70-7F25EDF470C7
P2860
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
CCR1+/CCR5+ mononuclear phagoc ...... ients with multiple sclerosis.
@ast
CCR1+/CCR5+ mononuclear phagoc ...... ients with multiple sclerosis.
@en
type
label
CCR1+/CCR5+ mononuclear phagoc ...... ients with multiple sclerosis.
@ast
CCR1+/CCR5+ mononuclear phagoc ...... ients with multiple sclerosis.
@en
prefLabel
CCR1+/CCR5+ mononuclear phagoc ...... ients with multiple sclerosis.
@ast
CCR1+/CCR5+ mononuclear phagoc ...... ients with multiple sclerosis.
@en
P2093
P2860
P1476
CCR1+/CCR5+ mononuclear phagoc ...... tients with multiple sclerosis
@en
P2093
J Hesselgesser
M K Cathcart
P Kivisäkk
R M Ransohoff
T L Sørensen
P2860
P304
P356
10.1016/S0002-9440(10)63017-9
P407
P577
2001-11-01T00:00:00Z